Alexandria Real Estate Equities
ARE
#2382
Rank
NZ$14.10 B
Marketcap
NZ$81.01
Share price
0.85%
Change (1 day)
-16.45%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

EPS for Alexandria Real Estate Equities (ARE)

EPS in 2023 (TTM): NZ$2.24

According to Alexandria Real Estate Equities 's latest financial reports the company's current EPS (TTM) is NZ-$15.13. In 2022 the company made an earnings per share (EPS) of NZ$5.62 a decrease over its 2021 EPS that were of NZ$6.81.

EPS history for Alexandria Real Estate Equities from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$2.24-60.19%
2022NZ$5.62-17.41%
2021NZ$6.81-35.32%
2020NZ$10.5389.03%
2019NZ$5.57-12.68%
2018NZ$6.38124.68%
2017NZ$2.84-179%
2016NZ-$3.59-221.95%
2015NZ$2.9562.38%
2014NZ$1.81-36.87%
2013NZ$2.8846.79%
2012NZ$1.96-36.63%
2011NZ$3.09-20.74%
2010NZ$3.90-21.66%
2009NZ$4.98-3.48%
2008NZ$5.168.3%
2007NZ$4.7616.23%
2006NZ$4.100.88%
2005NZ$4.06-9.27%
2004NZ$4.48-23.36%
2003NZ$5.8481.56%
2002NZ$3.227.19%
2001NZ$3.00-7.22%
2000NZ$3.2321.62%
1999NZ$2.66-8.07%
1998NZ$2.89-217.81%
1997NZ-$2.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.28-108.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$55.51-466.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.23-306.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ-$5.57-63.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$10.58-169.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.12-153.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$35.60-335.27%๐Ÿ‡บ๐Ÿ‡ธ USA